{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-002258","form_type":"8-K","ticker":"RYTM","cik":"0001649904","company_name":"RHYTHM PHARMACEUTICALS, INC.","filed_at":"2023-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.000723+00:00","generated_at":"2026-06-20T17:54:56.427109+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Rhythm Pharmaceuticals furnishes corporate slide deck; no material changes disclosed","bullets":["Slide deck posted to investors section of company website on January 9, 2023.","Deck covers setmelanotide for rare MC4R pathway diseases; no new data or milestones.","Exhibit contains only title slide and forward-looking statements; no financial or pipeline updates."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-002258","json":"https://secwatch.observer/filing/0001104659-23-002258.json","markdown":"https://secwatch.observer/filing/0001104659-23-002258.md","text":"https://secwatch.observer/filing/0001104659-23-002258.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649904/000110465923002258/0001104659-23-002258-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649904/000110465923002258/tm232248d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T17:54:56.427109+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}